Posted on: 02 September, 2021
The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling.
Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people.
A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disorders, spinal.....
Read more
Category: Neuroscience and Pain Research, Research Excellence, World-leading technology
Posted on: 24 August, 2021
New research is set to revolutionise the diagnosis and treatment of whiplash injuries, one of the most common and challenging injuries following a non-catastrophic motor vehicle collision.
The longitudinal study, conducted over more than five years, involved researchers from the Kolling Institute along with scientists from Northwestern University, University of Colorado and Stanford University.
Clo.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 20 August, 2021
Dr Cindy Shu will have a key role in building commercial capabilities at the Kolling after receiving a fellowship from the REDI (Researcher Exchange and Development within Industry) program.
The program provides financial support to Australian and international medical technology and pharmaceutical companies to bring the best talent in-house to work on priority medical research projects.
Cindy is o.....
Read more
Category: Musculoskeletal Research, Research Excellence, World-leading technology
Posted on: 07 May, 2021
An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities.
Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with less exposur.....
Read more
Category: World-leading technology
Posted on: 12 June, 2019
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer.
Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the world.
Professo.....
Read more
Category: World-leading technology, New Treatment